Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[In Process Citation]

Wolf, Schmitt, Weise

    Zentralblatt Fur Gynakologie
    |July 10, 1999
    PubMed
    Summary

    Prognostic factors like DNA ploidy and mitotic index offer valuable insights into uterine sarcoma outcomes, aiding in treatment selection for better patient prognosis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Psora and Syphilis.

    The Homoeopathic physician·2023
    Same author

    A Remarkable Case of Hydrocephalus.

    The Medical and physical journal·2018
    Same author

    Goitre in a colony of African cichlids.

    Journal of fish diseases·2018
    Same author

    The architecture of the surgical department.

    Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy·2006
    Same author

    Anastomotic devices for coronary surgery.

    Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy·2006
    Same author

    Neurootological Findings in Meningiomas of the Internal Auditory Canal and Cerebellopontine Angle.

    The international tinnitus journal·2001

    Area of Science:

    • Gynecologic Oncology
    • Pathology
    • Cancer Prognostics

    Background:

    • Uterine sarcomas are rare malignancies with variable prognoses.
    • Accurate prognostic markers are crucial for effective patient management and treatment planning.

    Purpose of the Study:

    • To evaluate the prognostic significance of various factors, including FIGO staging, DNA ploidy, and mitotic index, on survival and recurrence in uterine sarcoma patients.
    • To identify criteria that can assist in selecting patients for adjuvant therapy.

    Main Methods:

    • Retrospective analysis of clinical data from 78 uterine sarcoma patients.
    • Assessment of DNA ploidy using image cytometry and mitotic index counting.
    • Correlation of prognostic factors with median survival time and recurrence-free interval.

    Main Results:

    • FIGO staging was a significant prognostic factor for both median survival and recurrence-free interval.
    • Mitotic index and DNA ploidy demonstrated a significant impact on median survival time.
    • A lower mitotic index (<10/10 HPF) and diploidy were associated with improved prognosis.

    Conclusions:

    • DNA ploidy and mitotic index provide additional prognostic information for uterine sarcomas.
    • These factors can aid in identifying patients who may benefit from adjuvant therapy.

    Related Experiment Videos